• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Risky regulations: Is the FDA’s clunky process impeding progress?

Risky regulations: Is the FDA’s clunky process impeding progress?

May 23, 2011 By MassDevice staff

company

U.S. Rep. Erik Paulsen (R-Minn.) announced plans to push legislation to modernize and streamline FDA processes at the MedTech Investing Conference in Minneapolis last week.

High on Paulsen’s priorities are the development of an "Innovation Pathway" for pioneering medical devices and blocking a proposed $20 billion tax on the medical device industry.

Paulsen said he expects to meet with Dr. Jeffrey Shuren, head of the federal watchdog agency’s medical devices arm, to discuss his proposals.

The congressman from Eden Prairie, Minn., is a strong advocate for the medical device community. Paulsen, co-chairman of the House Medical Technology Caucus, gave the keynote address to the Advanced Medical Technology Assn.’s annual conference in Washington, D.C., last year.

The FDA product approval process is "inconsistent, inefficient and unpredictable," he said, according to MinnPost. “The No. 1 risk I hear from venture capitalists and investors … isn’t about market opportunity or product success,” he said. “The risk lies in the regulatory environment … brought on by the FDA.”

Paulsen also reiterated his aversion to the medical device tax, part of the Patient Protection & Affordable Care Act. He’s said that the tax, at 2.3 percent of revenue and set to kick in after 2013, will reduce medical technology jobs across the country. The money raised from the medical device tax will help foot the bill for President Obama’s health care reform legislation. 

Paulsen introduced a bill that would have repealed the device tax in April 2010, an effort he called the Defend Medical Innovation Act. He attempted to resurrect the measure in January, via a “Dear Colleague” letter to his fellow House members.

And he was set to testify before a House Oversight & Government Reform Subcommittee on Health Care on the FDA and medical devices, which was postponed indefinitely in April.

Filed Under: Food & Drug Administration (FDA), Healthcare Reform, News Well

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy